Skip to main content
. Author manuscript; available in PMC: 2020 Apr 5.
Published in final edited form as: Int J Pharm. 2019 Jan 31;560:11–18. doi: 10.1016/j.ijpharm.2019.01.050

Fig. 4.

Fig. 4.

Fine particle fraction of aerosolized phage formulations after 0, 1, 6 and 12-month storage. All formulations were dispersed using an Osmohaler™ at 100 L/min for 2.4 s. Data presented as mean ± standard deviation (n = 3). Student’s t test was used for statistical analysis. *, P < 0.05; **, P < 0.001. NOTE: FPF, fine particle fraction (< 5 µm in aerosol).